ArticleOncology reports2015

Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib.

Xinzhao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.